Publication | Closed Access

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

VaccinationVaccinologyVaccine DevelopmentCervical CancerHuman Papillomavirus VaccinesVirologyVaccine EfficacyYoung WomenPolyvalent VaccineMedicineVaccine ResearchTypes 6